Broker Research
June 10, 2025 / 13:02 IST
Reported Standalone quarterly numbers for Ipca Laboratories are:Net Sales at Rs 1,638.44 crore in March 2025 up 8.46% from Rs. 1,510.62 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 65.05 crore in March 2025 down 200.45% from Rs. 64.76 crore in March 2024.
EBITDA stands at Rs. 380.08 crore in March 2025 up 23.63% from Rs. 307.44 crore in March 2024.
Ipca Labs shares closed at 1,369.30 on June 06, 2025 (NSE) and has given -10.14% returns over the last 6 months and 16.37% over the last 12 months.
| Ipca Laboratories | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 1,638.44 | 1,662.68 | 1,510.62 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1,638.44 | 1,662.68 | 1,510.62 | | EXPENDITURE | | Consumption of Raw Materials | 351.67 | 352.01 | 363.37 | | Purchase of Traded Goods | 79.06 | 81.08 | 78.14 | | Increase/Decrease in Stocks | 14.79 | 26.17 | 42.20 | | Power & Fuel | -- | -- | -- | | Employees Cost | 377.12 | 358.48 | 333.22 | | Depreciation | 65.19 | 62.81 | 61.76 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 457.21 | 433.85 | 401.35 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 293.40 | 348.28 | 230.58 | | Other Income | 21.49 | 17.41 | 15.10 | | P/L Before Int., Excpt. Items & Tax | 314.89 | 365.69 | 245.68 | | Interest | 16.20 | 10.17 | 24.06 | | P/L Before Exceptional Items & Tax | 298.69 | 355.52 | 221.62 | | Exceptional Items | -281.54 | -- | -94.32 | | P/L Before Tax | 17.15 | 355.52 | 127.30 | | Tax | 82.20 | 87.96 | 62.54 | | P/L After Tax from Ordinary Activities | -65.05 | 267.56 | 64.76 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -65.05 | 267.56 | 64.76 | | Equity Share Capital | 25.37 | 25.37 | 25.37 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.56 | 10.55 | 2.55 | | Diluted EPS | -2.56 | 10.55 | 2.55 | | EPS After Extra Ordinary | | Basic EPS | -2.56 | 10.55 | 2.55 | | Diluted EPS | -2.56 | 10.55 | 2.55 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
